Log in to save to my catalogue

AB0822 SYSTEMIC SCLEROSIS ASSOCIATED ANTIBODIES POSITIVITY IN SYSTEMIC SCLEROSIS PATIENTS: SINGLE VS...

AB0822 SYSTEMIC SCLEROSIS ASSOCIATED ANTIBODIES POSITIVITY IN SYSTEMIC SCLEROSIS PATIENTS: SINGLE VS...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2854848744

AB0822 SYSTEMIC SCLEROSIS ASSOCIATED ANTIBODIES POSITIVITY IN SYSTEMIC SCLEROSIS PATIENTS: SINGLE VS. COMBINATION

About this item

Full title

AB0822 SYSTEMIC SCLEROSIS ASSOCIATED ANTIBODIES POSITIVITY IN SYSTEMIC SCLEROSIS PATIENTS: SINGLE VS. COMBINATION

Publisher

Kidlington: Elsevier B.V

Journal title

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1624-1624

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier B.V

More information

Scope and Contents

Contents

Autoantibodies (abs) are one of the most widely used tools currently in systemic sclerosis (SSc) as biomarkers. It has been described that 95% of patients with SSc have at least one ab and ≈5% >1. When looking only at abs associated with SSc (SSc-ab) that prevalence is reduced to 2.6%. The combination usually confers different clinical characterist...

Alternative Titles

Full title

AB0822 SYSTEMIC SCLEROSIS ASSOCIATED ANTIBODIES POSITIVITY IN SYSTEMIC SCLEROSIS PATIENTS: SINGLE VS. COMBINATION

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2854848744

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2854848744

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2023-eular.3782

How to access this item